Indication

Progressive vaccinia

Progressive vaccinia, historically termed vaccinia necrosum or vaccinia gangrenosum, is a rare, severe, and potentially fatal complication of smallpox vaccination using live vaccinia virus. Read more about Progressive vaccinia

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Progressive vaccinia therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Progressive vaccinia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Progressive vaccinia.

Progressive vaccinia, historically termed vaccinia necrosum or vaccinia gangrenosum, is a rare, severe, and potentially fatal complication of smallpox vaccination using live vaccinia virus.

It develops almost exclusively in individuals with severe cell-mediated immunodeficiencies, such as congenital T-cell defects, advanced HIV infection, hematologic malignancies, or profound immunosuppressive therapy.

Pathophysiologically, the host’s inability to mount an effective immune response allows uninhibited viral replication, characterized by an expanding, non-healing, painless ulceration and progressive tissue necrosis at the inoculation site.

Without prompt intervention, the viral infection relentlessly spreads to adjacent cutaneous tissue and disseminates via viremia to distant skin sites, mucous membranes, and visceral organs.

Personalize your experience

Follow Progressive vaccinia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it